JP2008137917A - Composition of biofilm control agent - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a composition for controlling the formation of a biofilm or for promoting the removal of the biofilm. <P>SOLUTION: The composition of a biofilm control agent comprises one or more compounds selected from the group consisting of thiols, carboxylic acid esters and amines, having specific structures, and a specified enzyme. The composition can be utilized more effectively by combining a specific surfactant and an enzyme stabilizer with the composition. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

  The present invention relates to a biofilm control agent composition, and more specifically, in various fields involving microorganisms, suppresses the production of biofilm and promotes the removal of biofilm, resulting from biofilm. The present invention relates to a biofilm control agent composition for preventing harm.

A biofilm is also called a biofilm or slime, and generally refers to an aqueous system in which microorganisms adhere to and grow on the surface of substances to produce macromolecular substances such as polysaccharides and proteins from within microbial cells to form structures. . When a biofilm is formed, harm caused by microorganisms occurs, causing problems in various industrial fields. For example, when a biofilm is formed in the piping of a food plant, the biofilm is peeled off and not only leads to contamination of foreign substances in the product, but also causes food poisoning due to microorganism-derived toxins. Furthermore, biofilm formation on the metal surface causes metal corrosion and promotes aging of the equipment.
Furthermore, compared to microorganisms that are dispersed and suspended in an aqueous system, microbial control agents such as bactericides and bacteriostatic agents are often unable to exert sufficient effects on microbial aggregates that have formed biofilms. . For example, in the medical field, many cases of nosocomial infections have been reported in recent years due to microorganisms remaining in narrow gaps and holes in medical devices to form biofilms. In the human oral cavity, it is well known that biofilms formed on teeth, so-called dental plaque (plaque), cause caries and periodontal disease, and these problems have been studied for a long time.

Until now, in order to suppress biofilms, the idea of preventing bacteria from growing by giving bactericidal action or bacteriostatic action to microorganisms, particularly bacteria, has been generally studied. Patent Document 1 and Patent Document 2 disclose that the number of bacteria can be reduced by using fatty acids, aliphatic alcohols, and the like, and as a result, adhesion of bacteria to the target substance can be prevented. In particular, Patent Document 1 shows that an emulsion prepared with an antibacterial oil phase and an emulsifier has an effect of reducing the number of bacteria in a relatively short time, which is based on the fact that the absolute number of bacteria per unit volume is low. It expresses the idea of suppressing adhesion to the material surface. Furthermore, Patent Document 3 discloses a toothpaste composition in which a non-aqueous active ingredient such as an anti-inflammatory agent is dissolved in an oily substance.
On the other hand, instead of sterilization, a method of removing the formed biofilm has been studied. Attempts have been made to remove biofilms using enzymes. Patent Document 4 discloses the use of various enzymes, and Patent Document 5 discloses the use of proteases.
JP-T-2002-524257 JP-T-2004-513153 JP 2005-289917 A JP-T-2001-508677 JP-A-6-262165

In Patent Document 1 or 2, bactericidal properties (reducing the number of bacteria by about the fourth power) are evaluated by evaluating microorganisms in a relatively short time within 60 minutes. However, the biofilm problem occurs in units of a long time of several days to several months, and it is practically difficult to connect to the suppression of biofilm formation by a short sterilization evaluation. Fatty acids and fatty alcohols listed as antibacterial oil phases do not have a sufficient bactericidal effect on all microorganisms (bacteria), especially in gram-negative bacteria that often form biofilms and cause problems On the other hand, it does not have the minimum inhibitory concentration (MIC), which is an indicator of the long-term bactericidal effect (Science of preservatives and fungicides; edited by John J. Kabbalah, Fragrance Journal, 1990) . Furthermore, according to the experiments by the inventors, the compositions described in Patent Documents 1 and 2 show a short-term (up to about 3 hours) bactericidal effect against Pseudomonas aeruginosa and Serratia bacteria among gram-negative bacteria. In the long term (one day or more), it was confirmed that the biofilm was formed as a result without showing bactericidal effect or even bacteriostatic effect to suppress bacterial growth. In addition, there are highly bactericidal bactericides such as cationic surfactants with high bactericidal properties and hypochlorite, but bactericidal properties are quickly lost when organic substances are present in the system. As described above, it is difficult to maintain the effect of reducing the number of bacteria over a long period of time.
For these reasons, it is difficult to fundamentally suppress the production of biofilms from the viewpoint of bactericidal and bacteriostatic.
As mentioned above, biofilms are formed from various substances such as cells, polysaccharides, and proteins, and it is difficult to completely remove biofilms by decomposing only some of these compounds. It is done. In the method of removing a biofilm using an enzyme, although a certain degree of removal effect is recognized, complete removal is difficult and it is not effective in suppressing biofilm formation. It grows and produces high-molecular substances such as polysaccharides and proteins.
That is, it is difficult to effectively control the biofilm even by the method of removing the biofilm.
Accordingly, an object of the present invention is to provide a composition for controlling or removing the production of biofilms composed of microorganisms and microorganism-producing substances in various regions, and a method for inhibiting and removing biofilm production. .

The present invention includes the following components (A) and (B):
(A) General formula (1), (2) and (3)

(Wherein R ¹ , R ² and R ⁴ represent a linear or branched alkyl group or alkenyl group having 8 to 14 carbon atoms, and R ³ represents a hydrogen atom or a linear or branched chain having 1 to 3 carbon atoms. EO represents an ethyleneoxy group, m and n are the average number of moles added, and m + n is a number from 0 to 15.)
The biofilm control agent composition containing 1 or more types of compounds (B) enzyme chosen from the group which consists of a compound represented by these is provided.
The present invention also provides a method of removing the biofilm that has been formed while bringing the biofilm control agent composition into contact with microorganisms to suppress the production of biofilm.

  ADVANTAGE OF THE INVENTION According to this invention, while suppressing the production | generation of a biofilm, a biofilm can be removed effectively and adhesion to the target object surface of a biofilm can be prevented effectively.

General formula (1) used as component (A) in the present invention:
R ¹ -SH (1)
In the compound represented by R ¹ , R ¹ is a linear or branched alkyl group or alkenyl group having 8 to 14 carbon atoms, preferably an alkyl group or alkenyl group having 10 to 12 carbon atoms, More preferably.
General formula (2) used as component (A) in the present invention:

R ² is a linear or branched alkyl group or alkenyl group having 8 to 14 carbon atoms, and R ³ is a hydrogen atom or a linear or branched alkyl group having 1 to 3 carbon atoms. It is. The alkyl group or alkenyl group represented by R ² may be linear or branched, but preferably has 10 to 12 carbon atoms. Moreover, as an alkyl group of R < ³ >, a C1-C2 thing is especially preferable.
General formula (3) used as component (A) in the present invention:

Or a salt thereof, R ⁴ is a linear or branched alkyl or alkenyl group having 8 to 14 carbon atoms, EO is an ethyleneoxy group, and m and n are the average number of moles added, m + n Is a number from 0 to 15.
The alkyl group or alkenyl group represented by R ⁴ may be linear or branched, but preferably has 10 to 12 carbon atoms. The number m + n of the ethyleneoxy group represented by EO is preferably 0 to 10, particularly preferably 0 to 5. Examples of the salt of the compound represented by the general formula (3) include mineral acid salts such as hydrochloride, sulfate and phosphate, and organic acid salts such as acetate and citrate.

  The weight concentration of the component (A) may be 1 ppm or more at the time of use, but is preferably 1 to 10000 ppm, more preferably 5 to 2000 ppm, and particularly preferably 10 to 1000 ppm from the viewpoints of economy and effects.

The component (B) used in the present invention is one selected from oxidoreductase (oxidoreductase), transferase (transferase), hydrase (hydrolase), lyase (isomerase), and isomerase (isomerase). The above enzymes are preferred.
Examples of the oxidoreductase (oxidoreductase) include peroxidase, superoxide dismutase, and lactate dehydrogenase.
Examples of the transferase (transferase) include serine hydroxymethyltransferase, aspartate aminotransferase, hexokinase and the like.
Examples of the hydrase (hydrolase) include amylase, cellulase, dextranase, glucanase, glucosidase, galactosidase, mannosidase, agarase, lactose, mutanase, lysozyme, chitinase, chitosanase, and the like; pepsin, trypsin, chymotrypsin, collagenase Proteolytic enzymes such as gelatinase, keratinase, elastase, subtilisin, papain, promeline, carboxypeptidase, aminopeptidase, thermolysin and achromopeptidase; and lipases such as lipases, cutinase and phospholipase.
Examples of lyases include alginate lyase, aldolase, serine dehydratase and the like.
Examples of the isomerase include UDP-glucose-4-epimerase and glucose phosphate isomerase.

Preferred as component (B) is hydrase or lyase, and more preferred is proteolytic enzyme, glucanase or alginate lyase.
The weight concentration of the enzyme which is the component (B) is not particularly limited, and can be appropriately selected depending on the kind thereof, but from the viewpoint of economy and effect, at the time of use, 0.01 to 20,000 ppm, Preferably it is 0.1-2,000 ppm, More preferably, it is 1-200 ppm.

Since the component (A) of the present invention has high hydrophobicity and low solubility in water, it can be stably present in an aqueous system using a surfactant (hereinafter also referred to as component (C)). This makes it possible to use this agent more effectively. Here, “stablely present in the aqueous system” refers to a state in which the highly hydrophobic component (A) is emulsified / dispersed / solubilized without being separated for a long time. A larger amount of component (A) can be emulsified / dispersed / solubilized per unit volume.
The type of surfactant that can be used in the present invention is not particularly limited, but it is desirable to use a surfactant that can stably cause component (A) to exist in the aqueous system and does not denature the enzyme that is component (B). . In particular, from the viewpoint of emulsification / dispersion / solubilization performance of the component (A), an anionic surfactant, a nonionic surfactant other than the component (A), or an amphoteric surfactant may be used among the surfactants. preferable.

  Examples of the anionic surfactant include lignin sulfonate, alkylbenzene sulfonate, alkyl sulfonate, polyoxyethylene (hereinafter referred to as POE) alkyl sulfonate, POE alkylphenyl ether sulfonate, POE alkylphenyl. Ether phosphate ester salt, POE arylphenyl ether sulfonate, alkyl sulfate ester salt, POE alkyl sulfate ester salt, POE aryl phenyl ether phosphate ester salt, naphthalene sulfonate, naphthalene sulfonate formalin condensate, POE tribenzylphenyl Ether sulfonate, alkyl phosphate, POE alkyl phosphate, POE tribenzylphenyl ether phosphate ester salt, dialkyl sulfosuccinate, fatty acid salt (soap), POE Al Ether acetates, and the like, it is more preferable to use inter alia alkyl sulfate and POE alkyl sulfates or POE alkyl ether acetates.

Nonionic surfactants include POE alkyl ether (excluding component (A)), POE alkylphenyl ether, polyoxypropylene / POE (block or random) alkyl ether, POE arylphenyl ether, POE styrenated phenyl Monovalent alcohol derivative type nonionic surfactants such as ether and POE tribenzylphenyl ether, (poly) glycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, POE sorbitan fatty acid ester, alkyl polyglycoside, fatty acid alkanolamide, etc. And polyhydric alcohol derivative type nonionic surfactants, among others, POE alkyl ethers (excluding component (A)), (poly) glycerin fatty acid esters, alkyl polyglycosides, It is more preferable to use Rubitan fatty acid ester or POE sorbitan fatty acid esters.
Examples of amphoteric surfactants include carboxybetaine, sulfobetaine, fatty acid amide betaine, and amine oxide. Among them, amine oxide is preferably used.
Surfactants can be used alone or in combination of two or more in order to enhance the emulsification / dispersion / solubilization performance.

The weight ratio (A) / (B) of the component (A) to the component (B) in the biofilm control agent composition is preferably 1,000,000 / 1 to 1/20000, and is 10,000 / 1 to 1/1000 is more preferable, 1,000 / 1 to 1/100 is more preferable, and 100/1 to 1/10 is particularly preferable.
The biofilm control agent composition preferably contains component (A) in an amount of 0.005 to 10% by weight, more preferably 0.05 to 5% by weight, particularly preferably 0.5 to 3% by weight. (B) is preferably contained in an amount of 0.0001 to 10% by weight, more preferably 0.001 to 5% by weight, and particularly preferably 0.01 to 2% by weight. Moreover, it is preferable that a biofilm control agent composition contains 0.01 to 50 weight% of (C) surfactant, and also 0.1 to 20 weight%.
The effective weight ratio (A) / (C) of the component (A) and the component (C) in the biofilm control agent composition is preferably 10/1 to 1/100, more preferably 5/1 to 1/50. 2/1 to 1/50 is more preferable, and 1/1 to 1/20 is particularly preferable.
In the method of adding the components (A) and (B) to the action system of the biofilm control agent composition of the present invention, the components (A) and (B) may be added separately so as to have the above-mentioned concentrations. It is also possible to prepare a composition in which the component (A) and the component (B) are blended in advance, and add it to the system. Moreover, the derivative | guide_body which uses the compound of general formula (1), (2) or (3) as a raw material may be added, and a component (A) may be produced | generated by reaction, such as a hydrolysis, in a system.

  As a form in the case of preparing a composition in which the component (A) and the component (B) of the composition of the present invention are blended in advance, various forms such as liquid, paste, powder, tablet and the like can be taken. is there. The biofilm control agent composition may be a one-component type in which all components are mixed, but it may be divided into several divided packages depending on ease of use.

When the biofilm control agent composition is made into a high-concentration liquid composition using water as a solvent in advance, the enzyme is stabilized for the purpose of preventing the inactivation of the component (B) during storage and maintaining its effect. An agent [hereinafter also referred to as component (D)] can be used. Enzyme stabilizers include boric acid or salts thereof, or boron compounds such as borax; polyols such as ethylene glycol, propylene glycol, glycerin, erythritol, xylitol, sorbitol; formic acid or salts thereof, acetic acid or salts thereof, etc. Short-chain carbonyl compounds; water-soluble calcium compounds such as calcium acetate, calcium chloride, and calcium gluconate can be used, and one or more of these enzyme stabilizers can be selected and used. Among these, boric acid or a salt thereof, polyols, formic acid or a salt thereof, and a water-soluble calcium compound are preferable, and boric acid or a salt thereof, and polyols are more preferable. In particular, it is preferable to use boric acid or a salt thereof in combination with a polyol.
Component (D) is preferably contained in the biofilm control agent composition in an amount of 0.01 to 20% by weight, more preferably 0.1 to 15% by weight.

  The biofilm control agent composition of the present invention suppresses the production of a biofilm composed of a microbial cell and a polymer substance produced by the fungus, and removes a biofilm already formed and attached to the surface of an object, It is an agent that controls biofilm adhesion on the surface of an object by maintaining these effects at the same time, and maintains the cleanliness or cleanliness, and does not kill bacteria themselves. For the purpose of killing bacteria, it can be used in combination with bactericides and antibacterial agents. In general, when a biofilm is formed, a situation occurs in which the bactericidal agent is hardly effective, but the composition of the present invention suppresses the formation of the biofilm, and the removal of the biofilm can sufficiently bring out the efficacy of the bactericidal agent. It becomes possible.

  The bactericides that can be used in the present invention are not particularly limited, but those that denature the enzyme as component (B) or deactivate the enzyme activity are not preferred. Preferable examples include chlorhexidine gluconate, triclosan, triclocarban, isopropylmethylphenol, alkyldiaminoethylglycine hydrochloride and the like. Moreover, if it is after making the biofilm control agent composition of this invention act, all the bactericides can be used effectively, without inhibiting the bactericidal effect by a biofilm.

  In the range that does not impair the purpose of the present invention, the biofilm control agent composition of the present invention is washed for the purpose of washing organic dirt such as proteins other than biofilm, starch, fats and oils, mud, and inorganic dirt such as scale. It is possible to mix components that improve the properties. Examples of such components include alkali agents, alkali builders, metal scavengers, and dispersants. Examples of the alkali agent include sodium hydroxide, potassium hydroxide, monoethanolamine, diethanolamine and the like. Examples of the alkali builder include sodium carbonate, potassium carbonate, sodium silicate, potassium silicate and the like. Examples of metal scavengers include nitrilotriacetate, ethylenediaminetetraacetate, iminodisuccinate, aspartate diacetate, aminomethylglycine diacetate and other aminocarboxylic acid derivatives, polyacrylic acid and / or salts thereof, polyacrylic acid / Polyelectrolyte compounds such as maleic acid copolymers and / or salts thereof, phosphate compounds such as tripolyphosphates, orthophosphates, pyrophosphates, 1-hydroxyethane-1,1-diphosphonic acid and / or Or salts thereof, aminotri (methylenephosphonic acid) and / or salts thereof, phosphonic acid compounds such as ethylenediaminetetra (methylenephosphonic acid) and / or salts thereof, and aluminosilicates such as A-type zeolite and B-type zeolite. . Other addable components include layered silicate, citric acid and / or salt thereof, aspartic acid and / or salt thereof, glutamic acid and / or salt thereof.

  Furthermore, as long as the object of the present invention is not impaired, a thickener, a viscosity modifier, a solvent, a fragrance, a colorant, an antioxidant, an antiseptic, a fluorescent agent, an excipient, a soil release agent, a bleaching agent, and a bleaching activity. An agent, a powdering agent, a granulating agent, a coating agent and the like can be blended.

  The biofilm control agent composition of the present invention is preferably used in the range of pH 2 to 12, preferably pH 4 to 11, more preferably pH 5 to 11.

The biofilm control agent composition of the present invention is effective when used as a water dilution in an aqueous system. The biofilm control agent composition is used in such a manner that the object is brought into contact with the water dilution. When using the biofilm control agent composition of the present invention, it is possible to remove the biofilm from the object without physical force such as wiping, brushing, water flow, etc., but for the biofilm removal in a short time, A physical force such as When the object covers a wide area, the mist may be sprayed using a spray device, or the foamed material may be sprayed using a foaming machine. Further, a water dilution of the composition may be poured or applied by brushing or the like. Alternatively, the object may be wiped off by impregnating the towel with a water-diluted solution. If the conditions for contact with microorganisms are satisfied, it is possible to attach or apply a water dilution of the composition to the surface where microorganisms may be present. The water dilution of the composition preferably has a weight concentration of component (A) at the time of use of 1 to 10,000 ppm.
In addition, depending on the object, it is possible to spread it in the form of cream or ointment without using a water dilution system. In this case, the component (A) is preferably provided in a form dissolved, dispersed, and emulsified in an appropriate solvent, and the weight concentration of the component (A) in use is preferably 1 to 10,000 ppm.

The present invention also provides a method of removing a biofilm that has been formed while bringing the biofilm control agent composition into contact with a microorganism to suppress the production of the biofilm. Here, the contact between the biofilm control agent composition and the microorganism is preferably carried out continuously.
The product of the present invention can be used in a wide range of fields where biofilms are a concern. For example, the present invention can be applied to cleaning agents for food production or beverage production plants with a high risk of bacterial contamination, drainage grooves such as kitchens or kitchens, and drainage pipes. It can also be applied to cooling water systems such as industrial cooling towers, desalination equipment, pulp and paper manufacturing systems, and circulating water systems such as bathtubs, pools, and artificial ponds. The present invention can also be applied to cleaning agents for medical devices that easily form biofilms, such as endoscopes, catheters, and artificial dialysis machines. Furthermore, since it has high safety, it can be used as a cleaning agent for human subjects, a dentifrice, an oral care agent, a denture care agent, a contact lens cleaner, and the like.

Example 1: Composition of biofilm control agent composition and assay component for biofilm formation inhibiting ability (A)
R ¹ -SH (1)
(A-1) C8 thiol [1-octanethiol, manufactured by Wako Pure Chemical Industries, Ltd., R ¹ = C8 alkyl]
(A-2) C10 thiol [1-decanethiol, manufactured by Wako Pure Chemical Industries, Ltd., R ¹ = C10 alkyl]
(A-3) C12 thiol [Thiocalcol 20, manufactured by Kao Corporation, R ¹ = C12 alkyl]
(A-4) C12 thiol (tertiary) [t-dodecanethiol, manufactured by Wako Pure Chemical Industries, Ltd., R ¹ = C12 alkyl]

R ² O—CO—CH ₃ (2)
(A-5) C8 alcohol-acetate [octyl acetate, manufactured by Wako Pure Chemical Industries, Ltd., R ² = C8 alkyl]
(A-6) C10 alcohol-acetate [decyl acetate, manufactured by Wako Pure Chemical Industries, Ltd., R ² = C10 alkyl]
(A-7) C12 alcohol-acetate ester [dodecyl acetate, manufactured by Wako Pure Chemical Industries, Ltd., R ² = C12 alkyl]

(A-8) C8 amine [Farmin 08D, manufactured by Kao Corporation, R ⁴ = C8 alkyl, m + n = 0]
(A-9) C10 amine [decylamine, manufactured by Wako Pure Chemical Industries, Ltd., R ⁴ = C10 alkyl, m + n = 0]
(A-10) C12 amine [Farmin 20D, manufactured by Kao Corporation, R ⁴ = C12 alkyl, m + n = 0]
(A-11) C12 amine hydrochloride [dodecylamine hydrochloride, manufactured by Wako Pure Chemical Industries, Ltd., R ⁴ = C12, m + n = 0]
(A-12) Cocoamine [Farmin CS, manufactured by Kao Corporation, R ⁴ = C8-14 alkyl (coconut composition), m + n = 0]
(A-13) Cocoamine acetate [Acetamine 24, manufactured by Kao Corporation, R ⁴ = C8-14 alkyl (coconut composition), m + n = 0]
(A-14) Cocoamine ethylene oxide 2-mole adduct [Amete 102, manufactured by Kao Corporation, R ⁴ = C 8-14 alkyl (coconut composition), m + n = 2]
(A-15) Cocoamine ethylene oxide 5 mol adduct [Amete 105, manufactured by Kao Corporation, R ⁴ = C 8-14 alkyl (coconut composition), m + n = 5]

Ingredient (A ')
R ₁ '-SH
(A′-1) C3 thiol [1-propanethiol, manufactured by Wako Pure Chemical Industries, Ltd., R ₁ ′ = C3 alkyl]
(A'-2) C3 thiol (secondary) [2-propanethiol, manufactured by Wako Pure Chemical Industries, Ltd., R ₁ '= C3 alkyl]
(A′-3) C6 thiol [1-hexanethiol, manufactured by Wako Pure Chemical Industries, Ltd., R ₁ ′ = C6 alkyl]
(A′-4) C16 thiol [1-hexadecanethiol, manufactured by Wako Pure Chemical Industries, Ltd., R ₁ ′ = C16 alkyl]
(A′-5) C18 thiol [1-octadecanethiol, manufactured by Wako Pure Chemical Industries, Ltd., R ₁ ′ = C18 alkyl]

R ₂ 'O-CO-CH ₃
(A'-6) C2 alcohol-acetate [ethyl acetate, manufactured by Wako Pure Chemical Industries, Ltd., R ₂ '= C2 alkyl]
(A'-7) C4 alcohol-acetate ester [butyl acetate, manufactured by Wako Pure Chemical Industries, Ltd., R ₂ '= C4 alkyl]
(A′-8) C6 alcohol-acetate [hexyl acetate, manufactured by Wako Pure Chemical Industries, Ltd., R ₂ ′ = C6 alkyl]
(A'-9) C16 alcohol-acetate [hexadecyl acetate, manufactured by Wako Pure Chemical Industries, Ltd., R ₂ '= C16 alkyl]
(A′-10) C18 alcohol-acetate ester [octadecyl acetate, manufactured by Wako Pure Chemical Industries, Ltd., R ₂ ′ = C18 alkyl]

(A'-11) C3 amine [propylamine, manufactured by Wako Pure Chemical Industries, Ltd., R ₄ '= C3 alkyl, m + n = 0]
(A′-12) C3 amine hydrochloride [propylamine hydrochloride, manufactured by Wako Pure Chemical Industries, Ltd., R ₄ ′ = C3 alkyl, m + n = 0]
(A′-13) C6 amine [hexylamine, manufactured by Wako Pure Chemical Industries, Ltd., R ₄ ′ = C6 alkyl, m + n = 0]
(A′-14) C6 amine hydrochloride [hexylamine hydrochloride, manufactured by Wako Pure Chemical Industries, Ltd., R ₄ ′ = C6 alkyl, m + n = 0]
(A′-15) Cured Tallowamine [Farmin 86T, manufactured by Kao Corporation, R ₄ ′ = C16,18 alkyl, m + n = 0]
(A′-16) C18 amine [Farmin 80, manufactured by Kao Corporation, R ₄ ′ = C18 alkyl, m + n = 0]
(A'-17) Oleylamine [Farmin O, manufactured by Kao Corporation, R ₄ '= C18 alkenyl, m + n = 0]
(A'-18) Cured tallow amine Ethylene oxide 2-mole adduct [Amit 302, manufactured by Kao Corporation, R ₄ '= C16,18 alkyl, m + n = 2]
(A'-19) Cured Tallowamine Ethylene oxide 20 mol adduct [Amit 320, manufactured by Kao Corporation, R ₄ '= C16,18 alkyl, m + n = 20]

Ingredient (B) Enzyme
(B-1) Proteolytic enzyme [Alcalase 2.5L, TypeDX, manufactured by Novozymes, Inc.]
(B-2) Proteolytic enzyme [Sabinase 16L, Type EX, manufactured by Novozymes, Inc.]
(B-3) Mixture of glucanase and proteolytic enzyme [Tunicase FN, manufactured by Daiwa Kasei Co., Ltd.]
(B-4) Alginate lyase [Alginate lyase S, manufactured by Nagase ChemteX Corporation]
(B-5) Dextranase [Dextranase L "Amano", Amano Enzyme Co., Ltd.]
(B-6) Amylase [Duramil, manufactured by Novozymes, Inc.]

Component (C) Surfactant [Numbers in parentheses indicate the average number of moles of ethylene oxide added. ]
<Anionic surfactant>
(C-1) Sodium lauryl sulfate [Emar 0, manufactured by Kao Corporation]
(C-2) Polyoxyethylene (2) Sodium lauryl ether sulfate [Emar 20C, manufactured by Kao Corporation]
<Nonionic surfactant>
(C-3) Polyoxyethylene (12) lauryl ether [Emulgen 120, manufactured by Kao Corporation]
(C-4) Lauryl glycoside [Mydol 12, manufactured by Kao Corporation]
(C-5) Polyoxyethylene (20) sorbitan monolaurate [Leodol TW-L120, manufactured by Kao Corporation]
<Amphoteric surfactant>
(C-6) Lauryldimethylamine oxide [Amphitol 20N, manufactured by Kao Corporation]

Component (A) or (A ′) is fixed at 1% by weight (effective amount), Component (B) is 1% by weight (apparent), Component (C) is 1% by weight, 3% by weight, 6% by weight, The concentration was selected from 10% by weight (effective amount), and the balance was blended with ion-exchanged water to obtain blends shown in Tables 1 to 3. 2 ml of this blend diluted to 1% by weight using Mueller Hinton medium (Nihon Becton Dickinson Co., Ltd.) was weighed into a 24-well microplate (Asahi Techno Glass Co., Ltd.).
Pseudomonas aeruginosa NBRC13275, Serratia marcescens NBRC12648, and Klebsiella pneumoniae ATCC13883 are each produced in soybean-Casein Digest Agar (SCD agar medium: Nippon Pharmaceutical Co., Ltd.) Was used to inoculate a test solution in the microplate using a sterilized bamboo skewer from a colony formed by pre-culturing at 37 ° C. for 24 hours. The culture solution was discarded after culturing at 37 ° C. for 48 hours, and the formation state of the biofilm adhered to the microplate wall was visually observed. The state of the biofilm is ◎ when the biofilm covers 0-20% of the plate wall, ○ when it covers 20-40%, △ when it covers 40-60%, and more than 60%. The state was marked with x. The results are shown in Tables 1-3.
When the product of the present invention was used, it was confirmed that biofilm formation could be remarkably suppressed.

Example 2: Composition of biofilm control agent composition and assay of biofilm removal ability Ingredient (A) or (A ') was fixed at 1 wt% (effective amount), and component (B) was 1 wt% (apparent) ), The composition (C) is 1% by weight, 3% by weight, 6% by weight, and 10% by weight (effective amount), and the balance is blended with ion-exchanged water, and the composition shown in Tables 1-3 It was. This blended composition was diluted to 1% by weight with ion exchange water to prepare a biofilm control agent.
Pseudomonas aeruginosa NBRC13275, Serratia marcescens NBRC12648, and Klebsiella pneumoniae ATCC13883 are each produced in soybean-Casein Digest Agar (SCD agar medium: Nippon Pharmaceutical Co., Ltd.) Into a 24-well microplate containing 2 mL each of Mueller Hinton medium using a sterilized bamboo skewer, using a sterilized bamboo skewer. Vaccinated. After culturing at 37 ° C. for 48 hours, the culture solution was discarded to form and attach a biofilm to the microplate wall. Immediately after, 2 mL of the prepared biofilm control agent was added and allowed to act at 40 ° C. for 20 minutes, then the biofilm control agent was discarded and the remaining state of the biofilm on the microplate wall was visually observed. The remaining state of the biofilm is ◎ when the biofilm covers the plate wall 0-20%, ○ when 20-40% is covered, △ when 40-60% is covered, △, when 60% or more is covered X. The results are shown in Tables 1-3.
When the product of the present invention was used, it was confirmed that the biofilm could be easily removed. In the comparative product containing the enzyme, although some effect was observed, it was not perfect.

Example 3: Biofilm control test in silicon tube Pseudomonas aeruginosa NBRC13275 and Klebsiella pneumoniae ATCC13883 were soybean-Casein Digest Agar (SCD agar medium: Nippon Pharmaceutical Co., Ltd.) ) Was used for pre-culture at 37 ° C. for 24 hours. 1 L of Mueller Hinton medium (Becton Dickinson) was inoculated with 1 platinum loop of the bacterial colonies on the agar medium, and quantified by Masterflex from Cole-Parmer Instrument Company. Using a pump system (system model No. 7553-80, head No. 7016-21), a culture solution in which bacteria are suspended in a silicon tube (inner diameter: 5 mm, outer diameter: 7 mm) manufactured by Aram Co., Ltd., has a flow rate of 50-60 mL It was circulated for 48 hours at 30 ° C./min to form a biofilm on the inner surface of the silicon tube. The culture solution is discarded, and the products 3, 7 and 10 of the present invention and the comparative products 1, 8, 20, 25 and 30 in Example 1 are 0.25% by weight, 1% by weight, and the Mueller Hinton medium is 10% by weight. % With ion-exchanged water. As a control, a 10% by weight solution of Mulan Hinton medium (no formulation added) was similarly tested.
Circulation was performed at 30 ° C. at a flow rate of 50 to 60 mL / min, and biofilm formation in the silicon tube was visually confirmed after 0 (before treatment), 5, 12, 24, and 48 hours. The biofilm formation state was evaluated as ◯ when no biofilm was formed, Δ when biofilm formation started and the inner surface of the silicon tube slightly colored, and x when biofilm was clearly formed.
The results are shown in Table 4-1 for Pseudomonas aeruginosa and Table 4-2 for Klebsiella.

  When the product of the present invention is used, the biofilm adhered to the inner surface of the silicon tube is effectively removed, the formation of a new biofilm is not recognized, and it has excellent biofilm control ability, It was confirmed that this was not due to the cleaning effect of the surfactant because the comparative product containing only the surfactant had no effect. In other words, it can be seen that it is important for biofilm control to make the biofilm production suppressing effect and the removing effect effective simultaneously. On the other hand, the comparative product showed a slight effect temporarily in the enzyme compounded product (Comparative products 1, 20, 25), but immediately formed a new biofilm.

Example 4 Biofilm Control Test of Biofilm Control Agent Composition at 40 ° C., One Month Preserved Product The biofilm composition shown in Table 5 was blended and Example 3 was used with Pseudomonas aeruginosa NBRC13275. A similar test was conducted. The results are shown in Table 5.

  The biofilm control agent composition (invention products 16 to 22) blended with the enzyme stabilizer showed the same effect as that immediately after blending even after storage at 40 ° C. for 1 month.

Claims (7)

The following component (A) and component (B):
(A) General formula (1), (2) and (3)

(Wherein R ¹ , R ² and R ⁴ represent a linear or branched alkyl group or alkenyl group having 8 to 14 carbon atoms, and R ³ represents a hydrogen atom or a linear or branched chain having 1 to 3 carbon atoms. EO represents an ethyleneoxy group, m and n are the average number of moles added, and m + n is a number from 0 to 15.)
The biofilm control agent composition containing 1 or more types of compounds (B) enzyme chosen from the group which consists of a compound represented by these.   Furthermore, the biofilm control agent composition of Claim 1 containing (C) surfactant other than a component (A).   The biofilm control agent composition according to claim 2, wherein (C) the surfactant is at least one selected from the group consisting of an anionic surfactant and a nonionic surfactant other than component (A).    The biofilm control agent composition according to any one of claims 1 to 3, wherein the component (B) is at least one enzyme selected from the group consisting of hydrase (hydrolase) and lyase (isomerase).   The biofilm control agent composition according to any one of claims 1 to 4, further comprising (D) an enzyme stabilizer. 6. The biofilm control composition according to claim 5, wherein the enzyme stabilizer is at least one selected from the group consisting of boric acid or a salt thereof, polyol, formic acid or a salt thereof, and a water-soluble calcium-containing compound. .   The biofilm control agent composition of any one of Claims 1-6 is made to contact with microorganisms, and while the production | generation of a biofilm is suppressed, the already formed biofilm is removed.